stemmacolore
Cerca

Circulating markers as gender-specific predictors of response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients” – MAGNETIC Trial

Circulating markers as gender-specific predictors of response to Immune Checkpoint Inhibitors in melanoma and non-small-cell lung cancer patients” – MAGNETIC Trial

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Capofila

Ente finanziatore

IOV - IRCCS

Principal Investigator

Dott.ssa Vanna Chiarion Sileni

Anno di finanziamento

2018
Torna in alto